Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

• Status: Completed
• Trial end date: 2014-08-01

Summary

To compare efficacy and safety of initial combination therapy of Gemigliptin versus Sitagliptin or Glimepiride with Metformin on Glucose Variability(MAGE, Glucose SD) in Patients With Type 2 Diabetes Mellitus.

• Phase: Phase 4

Details

• Lead Sponsor: LG Life Sciences
• Treatments: Glimepiride; Metformin; Sitagliptin Phosphate